|
2015 Journal Article Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis PopulationMarshall, Mark R., Polkinghorne, Kevan R., Kerr, Peter G., Agar, John W.M., Hawley, Carmel M. and McDonald, Stephen P. (2015). Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis Population. American Journal of Kidney Diseases, 66 (3), 489-498. doi: 10.1053/j.ajkd.2015.03.014 |
|
2015 Journal Article The impact of fibroblast growth factor-23 on the cardiovascular system in chronic kidney diseaseLee, Gavin, Krishnasamy, Rathika, Hawley, Carmel M. and Johnson, David W. (2015). The impact of fibroblast growth factor-23 on the cardiovascular system in chronic kidney disease. Expert Review of Endocrinology and Metabolism, 10 (6), 565-568. doi: 10.1586/17446651.2015.1079124 |
|
2015 Journal Article Standardised outcomes in nephrology - Haemodialysis (SONG-HD): Study protocol for establishing a core outcome set in haemodialysisTong, Allison, Manns, Braden, Hemmelgarn, Brenda, Wheeler, David C., Tugwell, Peter, Winkelmayer, Wolfgang C., van Biesen, Wim, Crowe, Sally, Kerr, Peter G., Polkinghorne, Kevan R., Howard, Kirsten, Pollock, Carol, Hawley, Carmel M., Johnson, David W., McDonald, Stephen P., Gallagher, Martin P., Urquhart-Secord, Rachel and Craig, Jonathan C. (2015). Standardised outcomes in nephrology - Haemodialysis (SONG-HD): Study protocol for establishing a core outcome set in haemodialysis. Trials, 16 (364) 364, 464-475. doi: 10.1186/s13063-015-0895-7 |
|
2015 Journal Article Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trialBadve, Sunil V., Zhang, Lei, Coombes, Jeff S., Pascoe, Elaine M., Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Alicia T. Morrish, Eugenie Pedagogos, Vlado Perkovic, Donna Reidlinger, Anish Scaria, Rowan Walker, Liza A. Vergara, Carmel M. Hawley, David W. Johnson and and on behalf of the HERO Study Collaborative Group (2015). Association between serum alkaline phosphatase and primary resistance to erythropoiesis stimulating agents in chronic kidney disease: a secondary analysis of the HERO trial. Canadian Journal of Kidney Health and Disease, 2 (33) 33, 1-10. doi: 10.1186/s40697-015-0066-5 |
|
2015 Journal Article An incident cohort study comparing survival on home hemodialysis and peritoneal dialysis (Australia and New Zealand Dialysis and Transplantation Registry)Nadeau-Fredette, Annie-Claire, Hawley, Carmel M., Pascoe, Elaine M., Chan, Christopher T., Clayton, Philip A., Polkinghorne, Kevan R., Boudville, Neil, Leblanc, Martine and Johnson, David W. (2015). An incident cohort study comparing survival on home hemodialysis and peritoneal dialysis (Australia and New Zealand Dialysis and Transplantation Registry). Clinical Journal of the American Society of Nephrology, 10 (8), 1397-1407. doi: 10.2215/CJN.00840115 |
|
2015 Journal Article Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney diseaseLo, Clement, Toyama, Tadashi, Hirakawa, Yoichiro, Jun, Min, Cass, Alan, Hawley, Carmel, Pilmore, Helen, Badve, Sunil V., Perkovic, Vlado and Zoungas, Sophia (2015). Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease. Cochrane Database of Systematic Reviews, 2015 (8) CD011798. doi: 10.1002/14651858.CD011798 |
|
2015 Journal Article Research Priorities in CKD: Report of a National Workshop Conducted in AustraliaTong, Allison, Crowe, Sally, Chando, Shingisai, Cass, Alan, Chadban, Steve J, Chapman, Jeremy R, Gallagher, Martin, Hawley, Carmel M, Hill, Sophie, Howard, Kirsten, Johnson, David W, Kerr, Peter G, McKenzie, Anne, Parker, David, Perkovic, Vlado, Polkinghorne, Kevan R, Pollock, Carol, Strippoli, Giovanni F.M, Tugwell, Peter, Walker, Rowan G, Webster, Angela C, Wong, Germaine and Craig, Jonathan C (2015). Research Priorities in CKD: Report of a National Workshop Conducted in Australia. American Journal of Kidney Diseases, 66 (2), 212-222. doi: 10.1053/j.ajkd.2015.02.341 |
|
2015 Journal Article Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney diseaseKrishnasamy, Rathika, Hawley, Carmel M., Stanton, Tony, Pascoe, Elaine M., Campbell, Katrina L., Rossi, Megan, Petchey, William, Tan, Ken-Soon, Beetham, Kassia S., Coombes, Jeff S., Leano, Rodel, Haluska, Brian A. and Isbel, Nicole M. (2015). Left ventricular global longitudinal strain is associated with cardiovascular risk factors and arterial stiffness in chronic kidney disease. BMC Nephrology, 16 (106) 106, 1-9. doi: 10.1186/s12882-015-0098-1 |
|
2015 Journal Article Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patientsTang, Wen, Grace, Blair, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil C., Brown, Fiona G., Clayton, Philip A. and Johnson, David W. (2015). Socio-economic status and peritonitis in Australian non-indigenous peritoneal dialysis patients. Peritoneal Dialysis International, 35 (4), 450-459. doi: 10.3747/pdi.2013.00004 |
|
2015 Journal Article The omega-3 fatty acids (fish oils) and aspirin in Vascular access outcomes in renal disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modificationsViecelli, Andrea K., Pascoe, Elaine, Polkinghorne, Kevan R., Hawley, Carmel, Paul-Brent, Peta-Anne, Badve, Sunil V., Cass, Alan, Heritier, Stephane, Kerr, Peter G., Mori, Trevor A., Robertson, Amanda, Seong, Hooi L. and Irish, Ashley B. (2015). The omega-3 fatty acids (fish oils) and aspirin in Vascular access outcomes in renal disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications. BMC Nephrology, 16 (1) 89, 1-8. doi: 10.1186/s12882-015-0089-2 |
|
2015 Journal Article Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney diseaseKrishnasamy, Rathika, Isbel, Nicole M., Hawley, Carmel M., Pascoe, Elaine M., Burrage, Matthew, Leano, Rodel, Haluska, Brain A., Marwick, Thomas H. and Stanton, Tony (2015). Left ventricular global longitudinal strain (GLS) is a superior predictor of all-cause and cardiovascular mortality when compared to ejection fraction in advanced chronic kidney disease. PLoS ONE, 10 (5) 0127044, 1-15. doi: 10.1371/journal.pone.0127044 |
|
2015 Journal Article N-terminal pro-B-type natriuretic peptide variability in stable dialysis patientsFahim, Magid A, Hayen, Andrew, Horvath, Andrea R, Dimeski, Goce, Coburn, Amanda, Johnson, David W, Hawley, Carmel M, Campbell, Scott B and Craig, Jonathan C (2015). N-terminal pro-B-type natriuretic peptide variability in stable dialysis patients. Clinical Journal of the American Society of Nephrology, 10 (4), 620-629. doi: 10.2215/CJN.09060914 |
|
2015 Journal Article Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practiceFahim, Magid A., Hayen, Andrew D., Horvath, Andrea R., Dimeski, Goce, Coburn, Amanda, Tan, Ken-Soon, Johnson, David W., Craig, Jonathan C., Campbell, Scott B. and Hawley, Carmel M. (2015). Biological variation of high sensitivity cardiac troponin-T in stable dialysis patients: implications for clinical practice. Clinical Chemistry and Laboratory Medicine, 53 (5), 715-722. doi: 10.1515/cclm-2014-0838 |
|
2015 Journal Article Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trialCho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Clarke, Margaret and Topley, Nicholas (2015). Utility of urinary biomarkers in predicting loss of residual renal function: the balANZ trial. Peritoneal Dialysis International, 35 (2), 159-171. doi: 10.3747/pdi.2013.00170 |
|
2015 Journal Article The rationale and design of the beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility studyRoberts, Matthew A., Pilmore, Helen L., Ierino, Francesco L., Badve, Sunil V., Cass, Alan, Garg, Amit X., Hawley, Carmel M., Isbel, Nicole M., Krum, Henry, Pascoe, Elaine M., Tonkin, Andrew M., Vergara, Liza A., Perkovic, Vlado and The BLOCADE Study Collaborative Group (2015). The rationale and design of the beta-blocker to LOwer CArdiovascular Dialysis Events (BLOCADE) feasibility study. Nephrology, 20 (3), 140-147. doi: 10.1111/nep.12362 |
|
2015 Journal Article The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitisStevenson, Sarah, Tang, Wen, Cho, Yeoungjee, Mudge, David W., Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2015). The role of monitoring vancomycin levels in patients with peritoneal dialysis-associated peritonitis. Peritoneal Dialysis International, 35 (2), 222-228. doi: 10.3747/pdi.2013.00156 |
|
2015 Journal Article A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trialJohnson, David W., Pascoe, Elaine M., Badve, Sunil V., Dalziel, Kim, Cass, Alan, Clarke, Philip, Ferrari, Paolo, McDonald, Stephen P., Morrish, Alicia T., Pedagogos, Eugenie, Perkovic, Vlado, Reidlinger, Donna, Scaria, Anish, Walker, Rowan, Vergara, Liza A., Hawley, Carmel M., on behalf of the HERO Study Collaborative Group and Fassett, Rob (2015). A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the handling erythropoietin resistance with oxpentifylline (HERO) trial. American Journal of Kidney Diseases, 65 (1), 49-57. doi: 10.1053/j.ajkd.2014.06.020 |
|
2015 Journal Article End-Stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy - outcomes in 66 consecutive ANZDATA registry casesMallett, Andrew, Tang, Wen, Hart, Gareth, McDonald, Stephen P., Hawley, Carmel M., Badve, Sunil V., Boudville, Neil, Brown, Fiona G., Campbell, Scott B., Clayton, Philip A. and Johnson, David W. (2015). End-Stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy - outcomes in 66 consecutive ANZDATA registry cases. American Journal of Nephrology, 42 (3), 177-184. doi: 10.1159/000440815 |
|
2015 Journal Article Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis PatientsCho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret and Topley, Nicholas (2015). Baseline Serum Interleukin-6 Predicts Cardiovascular Events in Incident Peritoneal Dialysis Patients. Peritoneal Dialysis International, 35 (1), 35-42. doi: 10.3747/pdi.2013.00272 |
|
2015 Journal Article Outcomes of integrated home dialysis care: a multi-centre, multi-national registry studyNadeau-Fredette, Annie-Claire, Chan, Christopher T., Cho, Yeoungjee, Hawley, Carmel M., Pascoe, Elaine M., Clayton, Philip A., Polkinghorne, Kevan R., Boudville, Neil, Leblanc, Martine and Johnson, David W. (2015). Outcomes of integrated home dialysis care: a multi-centre, multi-national registry study. Nephrology Dialysis Transplantation, 30 (11), 1897-1904. doi: 10.1093/ndt/gfv132 |
